Top

International Urogynecology Journal

Published in:

01-01-2012 | Original Article

Incidence and risk factors for reoperation of surgically treated pelvic organ prolapse

Authors: Patrick Dällenbach, Carol Jungo Nancoz, Isabelle Eperon, Jean-Bernard Dubuisson, Michel Boulvain

Published in: International Urogynecology Journal | Issue 1/2012

Abstract

Introduction and hypothesis

The objective of our study was to estimate the incidence and to identify the risk factors for reoperation of surgically treated pelvic organ prolapse (POP).

Methods

We conducted a nested case–control study among 1,811 women who underwent POP surgery from January 1988 to June 2007. Cases (n = 102) were women who required reoperation for POP following the first intervention through December 2008. Controls (n = 226) were women randomly selected from the same cohort who did not require reoperation.

Results

The incidence of POP reoperation was 5.1 per 1,000 women-years. The cumulative incidence was 5.6%. Risk factors included preoperative prolapse in more than two vaginal compartments (adjusted OR 5.2; 95% CI 2.8–9.7), history of surgery for POP and/or urinary incontinence (adjusted OR 3.2; 95% CI 1.5–7.1), and sexual activity (adjusted OR 2.0; 95% CI 1.0–3.7).

Conclusions

The risk of POP reoperation is relatively low and is associated with preexisting weakness of pelvic tissues.

Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89:501–506PubMedCrossRef

Fialkow MF, Newton KM, Lentz GM, Weiss NS (2008) Lifetime risk of surgical management for pelvic organ prolapse or urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 19:437–440PubMedCrossRef

Smith FJ, Holman CD, Moorin RE, Tsokos N (2010) Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet Gynecol 116:1096–1100PubMedCrossRef

Wiskind AK, Creighton SM, Stanton SL (1992) The incidence of genital prolapse after the Burch colposuspension. Am J Obstet Gynecol 167:399–404, discussion 404–5PubMed

Kjolhede P, Noren B, Ryden G (1996) Prediction of genital prolapse after Burch colposuspension. Acta Obstet Gynecol Scand 75:849–854PubMedCrossRef

Jakus SM, Shapiro A, Hall CD (2008) Biologic and synthetic graft use in pelvic surgery: a review. Obstet Gynecol Surv 63:253–266PubMedCrossRef

Fatton B, Amblard J, Debodinance P, Cosson M, Jacquetin B (2007) Transvaginal repair of genital prolapse: preliminary results of a new tension-free vaginal mesh (Prolift technique)—a case series multicentric study. Int Urogynecol J Pelvic Floor Dysfunct 18:743–752PubMedCrossRef

Yamada BS, Govier FE, Stefanovic KB, Kobashi KC (2006) Vesicovaginal fistula and mesh erosion after Perigee (transobturator polypropylene mesh anterior repair). Urology 68(1121):e5–e7PubMed

Diez-Itza I, Aizpitarte I, Becerro A (2007) Risk factors for the recurrence of pelvic organ prolapse after vaginal surgery: a review at 5 years after surgery. Int Urogynecol J Pelvic Floor Dysfunct 18:1317–1324PubMedCrossRef

10.

Clark AL, Gregory T, Smith VJ, Edwards R (2003) Epidemiologic evaluation of reoperation for surgically treated pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol 189:1261–1267PubMedCrossRef

11.

Price N, Slack A, Jwarah E, Jackson S (2008) The incidence of reoperation for surgically treated pelvic organ prolapse: an 11-year experience. Menopause Int 14:145–148PubMedCrossRef

12.

Salvatore S, Athanasiou S, Digesu GA, Soligo M, Sotiropoulou M, Serati M, Antsaklis A, Milani R (2009) Identification of risk factors for genital prolapse recurrence. Neurourol Urodyn 28:301–304PubMedCrossRef

13.

Whiteside JL, Weber AM, Meyn LA, Walters MD (2004) Risk factors for prolapse recurrence after vaginal repair. Am J Obstet Gynecol 191:1533–1538PubMedCrossRef

14.

Denman MA, Gregory WT, Boyles SH, Smith V, Edwards SR, Clark AL (2008) Reoperation 10 years after surgically managed pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol 198(555):e1–e5PubMed

15.

Baden W, Walker T (1992) Surgical repair of vaginal defects. Lippincott, Philadelphia

16.

Bump RC, Mattiasson A, Bo K, Brubaker LP, DeLancey JO, Klarskov P, Shull BL, Smith AR (1996) The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 175:10–17PubMedCrossRef

17.

Hirsch H, Käser O, Iklé F (1997) Atlas of gynecologic surgery. Thieme, New York

18.

Dubuisson JB, Yaron M, Wenger JM, Jacob S (2008) Treatment of genital prolapse by laparoscopic lateral suspension using mesh: a series of 73 patients. J Minim Invasive Gynecol 15:49–55PubMedCrossRef

19.

Fialkow MF, Newton KM, Weiss NS (2008) Incidence of recurrent pelvic organ prolapse 10 years following primary surgical management: a retrospective cohort study. Int Urogynecol J Pelvic Floor Dysfunct 19:1483–1487PubMedCrossRef

20.

Buchsbaum GM, Duecy EE, Kerr LA, Huang LS, Perevich M, Guzick DS (2006) Pelvic organ prolapse in nulliparous women and their parous sisters. Obstet Gynecol 108:1388–1393PubMedCrossRef

21.

Jack GS, Nikolova G, Vilain E, Raz S, Rodriguez LV (2006) Familial transmission of genitovaginal prolapse. Int Urogynecol J Pelvic Floor Dysfunct 17:498–501PubMedCrossRef

22.

Moalli PA, Shand SH, Zyczynski HM, Gordy SC, Meyn LA (2005) Remodeling of vaginal connective tissue in patients with prolapse. Obstet Gynecol 106:953–963PubMedCrossRef

23.

Norton PA, Baker JE, Sharp HC, Warenski JC (1995) Genitourinary prolapse and joint hypermobility in women. Obstet Gynecol 85:225–228PubMedCrossRef

24.

Dallenbach P, Kaelin-Gambirasio I, Dubuisson JB, Boulvain M (2007) Risk factors for pelvic organ prolapse repair after hysterectomy. Obstet Gynecol 110:625–632PubMedCrossRef

25.

Carey M, Higgs P, Goh J, Lim J, Leong A, Krause H, Cornish A (2009) Vaginal repair with mesh versus colporrhaphy for prolapse: a randomised controlled trial. BJOG 116:1380–1386PubMedCrossRef

Title: Incidence and risk factors for reoperation of surgically treated pelvic organ prolapse
Authors: Patrick Dällenbach
Carol Jungo Nancoz
Isabelle Eperon
Jean-Bernard Dubuisson
Michel Boulvain
Publication date: 01-01-2012
Publisher: Springer-Verlag
Published in: International Urogynecology Journal / Issue 1/2012
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-011-1483-3

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Incidence and risk factors for reoperation of surgically treated pelvic organ prolapse

Abstract

Introduction and hypothesis

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Introduction and hypothesis

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2012

TVT-O vs. TVT for the treatment of SUI: a non-inferiority study

Traditional native tissue versus mesh-augmented pelvic organ prolapse repairs: providing an accurate interpretation of current literature

Measurement of the 3D geometry of the fascial arches in women with a unilateral levator defect and “architectural distortion”

Vaginal hysterectomy and risk of pelvic organ prolapse and stress urinary incontinence surgery

Leukoplakia of the bladder: a case report and literature review

Single-incision vaginal approach to treat cystocele and vault prolapse with an anterior wall mesh anchored apically to the sacrospinous ligaments